[ad_1]
During the previous day, 628 new cases of coronavirus were detected in Lithuania. A total of 206,290 people have already registered with COVID-19 in the country. Currently sick 6767.
Another 5 patients died on Monday. The virus has already claimed 3,416 victims in Lithuania.
Incidence of coronavirus infection in the last 14 days 100 thousand. the population reaches 230 cases.
794 people recovered in the last day.
192,118 people have already recovered from COVID-19.
The first dose of the vaccine was administered to 6,385 people on Monday.
The second dose of the vaccine was received by 924 people on Monday.
In Lithuania, 260,616 people received the first dose of the vaccine.
A total of 100,185 people had already received the second dose of the vaccine.
360,801 vaccines have already been used in Lithuania.
6725 PCR samples were analyzed during the previous day. A total of 2,196,461 samples have already been analyzed.
763 COVID-19 patients are currently being treated in Lithuanian hospitals, 80 of them undergoing resuscitation, Statistics Lithuania reported Tuesday.
Oxygen is added to 727 patients and 43 patients receive artificial lung ventilation.
61 people were hospitalized for COVID-19 per day.
In Lithuania, since the start of the pandemic, COVID-19 has affected 206 thousand people. 290 people.
According to the declared data, 50 thousand are still sick. 736 infected, but it is statistically estimated that 6739 people should be sick.
A total of 3,416 people have died in Lithuania since COVID-19. 3,416 deaths have been linked to this infectious disease, directly and indirectly.
Five people died from COVID-19 last day, between the ages of 70 and 89, according to data released by Statistics Lithuania on Tuesday.
Three of the dead were between 80 and 89 years old and two between 70 and 79 years old.
All of these people died in hospitals.
The Statistics Department notes that the number of deaths per day is preliminary and can be replenished with records delayed within a few days.
A total of 3,416 people have died in Lithuania since COVID-19. 6908 deaths are directly and indirectly related to this infectious disease.
Most of the deaths from COVID-19 (1,226 people) were in the age group 80-89 years. The four dead were between 20 and 29 years old.
“British” atmaina Vilniuje
In Vilnius, the so-called British strain of coronavirus (COVID-19) may already reach about half of all new cases and be dominant, says Aistis Šimaitis, project manager of the Government Chancellery’s Project Management Group.
A. Šimaitis, who presented the COVID-19 situation in Lithuania during the Government meeting, pointed out that the official sequencing data is several weeks late and the latest figures show 20%. “British” mutations in Vilnius, but according to other data (loss of the S gene signal) this number can reach 50 percent.
“The sequence data is February 20, if we want to see the distribution of the strains more quickly, we can look at other parameters, such as the loss of the S parameter gene in a PCR test, we can see this quite quickly.
If we look at February 20, that percentage was roughly 20, which was roughly the amount of the British variety in the Vilnius County sequencing data, but we can see that in the last month that percentage has risen to 50, ”he said. A. Šimaitis.
“This is a very strong correlation between the number of S gene dropouts and the number of British strains. Propagated and between one and a half to twice as lethal,” said a government spokesman.
He also noted that the situation in the counties is very different and, in general, the “Spanish” strain of the virus still dominates in Lithuania.
Quarantine restrictions
It is proposed to extend the movement restriction until the end of the month in 16 municipalities, including Vilnius and its district, Klaipėda, Neringa, according to the draft government decision registered on Monday.
The Ministry of Health proposes that the movement restrictions be extended until April 1 between Biržai district, Klaipėda city, Kupiškis district, Marijampolė, Neringa, Panevėžys city and district, Šalčininkai district, Širvintos district, Švenčionys district, Trakai district, Utena district, Varėna district, Vilnius City and District and Visaginas municipalities.
The prohibition to enter and leave them would continue to apply, except in exceptional cases, and it would also be possible to move between the municipalities of the ring.
According to the ministry, it is proposed to continue with movement restrictions in those municipalities where the number of new cases of COVID-19 in 14 days is 100,000. the population reaches 200 and more.
Vaccine delivery
On Monday morning, the thirteenth shipment of BioNTech and Pfizer (COVID-19) coronavirus vaccines arrived in Lithuania: 31 thousand. 590 doses, due to temperature fluctuations during transport, raised suspicions about part of its quality, reported the Ministry of Health (SAM).
According to SAM, when the cargo arrived in Lithuania, the manufacturer reported that the temperature of the cargo may deviate from the required standard during transportation. Suspicion rose to more than 11,000. 700 doses of the vaccine, for which its sale was temporarily suspended and its quality evaluation began.
On Monday afternoon, when the manufacturer reported that 5 thousand. 850 doses of the vaccine can be used, they are taken to vaccination centers. The remaining vaccines will be stored in the warehouse of the Health Emergencies Center until the manufacturer confirms that they can be used, according to the notification.
Stopping vaccination with AstraZeneca
Germany stopped vaccinating against a coronavirus infection with a vaccine developed by AstraZeneca on incidents of blood clots in vaccinated people in Europe on Monday, and said the situation needed to be thoroughly analyzed.
“Following new reports of cerebrovascular thrombosis vaccination in Germany and Europe, the PEI (Paul Erhlich Institute) believes that more research is needed,” the Health Ministry said, citing the country’s authority responsible for oversight of vaccination. .
“The European Medicines Agency (EMA) will decide whether and how the new findings will affect the approval of this vaccine,” the ministry added.
Several European countries, including Ireland and the Netherlands, have also frozen the use of AstraZeneca, a drug developed in collaboration with the University of Oxford.
The UK and Sweden-based company and Oxford University said there was no link between the vaccine and increased blood clotting.
